Skip to main content

Paula-Ann Reid

MPH
Senior Healthcare Data Analyst
New York, NY, US
Publications

Read their latest work

Article

Analysis of hypoglycemia in claims data and considerations for cell and gene therapy eligibility for people with type 1 diabetes

06 August 2026 - by Rebecca Smith, Carrie Scott, Winston Fopalan, Paula-Ann Reid
Cell and gene therapies to treat Type 1 diabetes are on the horizon. Without accurate information on severe hypoglycemia events associated with Type 1 diabetes, health plans risk underestimating the number of people with the condition.
Article

Impact of state and federal insulin out-of-pocket cost caps on the type 1 diabetes population

16 March 2026 - by Rebecca Smith, Carrie Scott, Hope Norris, Paula-Ann Reid
Looking at Medicare and commercial insurance data, we found 55% of the U.S. population with Type 1 diabetes are exposed to high out-of-pocket costs for insulin.